Influenza vaccine indications and usage

Revision as of 13:04, 9 January 2014 by Mohamed Moubarak (talk | contribs) (Created page with "__NOTOC__ {{Influenza vaccine}} {{CMG}}; {{AE}} {{MM}} ==Indications and Usage== Flublok is a vaccine indicated for active immunization against disease caused by influenza vir...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Influenza vaccine
FLUBLOK® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Indications and Usage

Flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use in persons 18 through 49 years of age.[1]

References

  1. "FLUBLOK (INFLUENZA VACCINE) INJECTION, SOLUTION [PROTEIN SCIENCES CORPORATION]". Text " accessdate" ignored (help)

Adapted from the FDA Package Insert.